These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1365672)

  • 1. Imipramine and 2-hydroxyimipramine: comparative cardiotoxicity and pharmacokinetics in swine.
    Pollock BG; Perel JM
    Psychopharmacology (Berl); 1992; 109(1-2):57-62. PubMed ID: 1365672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative cardiotoxicity of nortriptyline and its isomeric 10-hydroxymetabolites.
    Pollock BG; Everett G; Perel JM
    Neuropsychopharmacology; 1992 Jan; 6(1):1-10. PubMed ID: 1571065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple-dose pharmacokinetics of imipramine and its major active and conjugated metabolites in depressed patients.
    Sutfin TA; Perini GI; Molnar G; Jusko WJ
    J Clin Psychopharmacol; 1988 Feb; 8(1):48-53. PubMed ID: 3350999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative pharmacodynamic study of the arrhythmogenicity of antidepressants, fluvoxamine and imipramine, in guinea pigs.
    Ohtani H; Odagiri Y; Sato H; Sawada Y; Iga T
    Biol Pharm Bull; 2001 May; 24(5):550-4. PubMed ID: 11379778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of imipramine and its major metabolites in pregnant rats and their fetuses following a single dose.
    DeVane CL; Simpkins JW
    Drug Metab Dispos; 1985; 13(4):438-42. PubMed ID: 2863107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic metabolism of imipramine after prolonged administration of the drug to rats. An in vivo study.
    Melzacka M; Danek L; Adamus A
    Pol J Pharmacol Pharm; 1987; 39(4):379-86. PubMed ID: 3449809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of several tricyclic antidepressants on the hemodynamics and myocardial contractility of the anesthetized dogs.
    Jandhyala BS; Steenberg ML; Perel JM; Manian AA; Buckley JP
    Eur J Pharmacol; 1977 Apr; 42(4):403-10. PubMed ID: 856616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modelling of non-linear pharmacokinetics in sheep after short-term infusion of cardiotoxic doses of imipramine.
    Meineke I; Schmidt W; Nottrott M; Schröder T; Hellige G; Gundert-Remy U
    Pharmacol Toxicol; 1997 Jun; 80(6):266-71. PubMed ID: 9225362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of imipramine to plasma protein and to brain tissue: relationship to CSF tricyclic levels in man.
    Potter WZ; Muscettola G; Goodwin FK
    Psychopharmacology (Berl); 1979 May; 63(2):187-92. PubMed ID: 112637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The analysis and disposition of imipramine and its active metabolites in man.
    Sutfin TA; DeVane CL; Jusko WJ
    Psychopharmacology (Berl); 1984; 82(4):310-7. PubMed ID: 6427820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular profile of 5 novel nitrate-esters: a comparative study with nitroglycerin in pigs with and without left ventricular dysfunction.
    van Woerkens LJ; van der Giessen WJ; Verdouw PD
    Br J Pharmacol; 1991 Sep; 104(1):7-14. PubMed ID: 1786521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism of imipramine in vitro by isozyme CYP2D6 expressed in a human cell line, and observations on metabolite stability.
    Coutts RT; Su P; Baker GB; Daneshtalab M
    J Chromatogr; 1993 Jun; 615(2):265-72. PubMed ID: 8335704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Active metabolites of imipramine and desipramine in man.
    Potter WZ; Calil HM; Sutfin TA; Zavadil AP; Jusko WJ; Rapoport J; Goodwin FK
    Clin Pharmacol Ther; 1982 Mar; 31(3):393-401. PubMed ID: 7060321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analysis of the cardiotoxicity proclivities of second generation antihistamines in an experimental model predictive of adverse clinical ECG effects.
    Hey JA; del Prado M; Sherwood J; Kreutner W; Egan RW
    Arzneimittelforschung; 1996 Feb; 46(2):153-8. PubMed ID: 8720304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comprehensive investigation of plasma and brain regional pharmacokinetics of imipramine and its metabolites during and after chronic administration in the rat.
    Besret L; Debruyne D; Rioux P; Bonvalot T; Moulin M; Zarifian E; Baron JC
    J Pharm Sci; 1996 Mar; 85(3):291-5. PubMed ID: 8699331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and acute cardiovascular effects of menogaril in patients with metastatic tumors.
    Piergies AA; Benson AB
    Int J Clin Pharmacol Ther; 1995 Feb; 33(2):63-9. PubMed ID: 7757312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population pharmacokinetics of imipramine in children.
    Tamayo M; Fernández de Gatta MM; García MJ; Domínguez-Gil A
    Eur J Clin Pharmacol; 1992; 43(1):89-92. PubMed ID: 1505617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The distribution of imipramine and desipramine in rat brain regions after single and chronic administration of imipramine.
    Szymura-Oleksiak J; Panas M; Chruściel W
    Pol J Pharmacol Pharm; 1984; 36(1):21-6. PubMed ID: 6462958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous pharmacokinetics of 2-hydroxyimipramine in alcoholics and normal controls.
    Ciraulo DA; Barnhill JG; Jaffe JH; Ciraulo AM; Tarmey MF
    J Stud Alcohol; 1990 Jul; 51(4):366-72. PubMed ID: 2359311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imipramine and its metabolites: relationship to cerebral catecholamines in rats in vivo.
    Barkai AI; Suckow RF; Cooper TB
    J Pharmacol Exp Ther; 1984 Aug; 230(2):330-5. PubMed ID: 6747838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.